Borres, Rayver .
HRN: 22-61-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2023
AMPICILLIN 250MG (VIAL)
02/13/2023
02/19/2023
IV
250mg
Q6hr
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes